Pharmacology News

Two studies assessing the use of algorithm-driven prompts meant to improve antibiotic selection for patients hospitalized with pneumonia or UTIs showed the prompts were effective, researchers found.

The FDA approved pivmecillinam tablets to treat uncomplicated urinary tract infections caused by susceptible isolates of Escherichia coli, Proteus mirabilis and Staphylococcus saprophyticus for women, according to an agency press release.

Among patients with chronic coronary syndrome, women were less likely than men to be treated with lipid-lowering therapy, researchers reported at ESC Preventive Cardiology 2024.

BOSTON — Editors of Annals of Internal Medicine compiled a list of studies published over the past year that they said have important implications for internal medicine physicians.

Multidrug-resistant bacteria were believed to spread to rooms in a Japanese pediatric ward through sink drains and plumbing, as replacing contaminated sinks did not end the outbreak, according to a recent study.

BOSTON — There is some evidence that cannabinoids may help with neuropathic pain, chemotherapy-induced nausea/vomiting and MS-associated spasticity, “but it’s not exactly a slam dunk,” a speaker said.

HOUSTON — A 6-month implementation study improved nurses’ evaluation of penicillin allergies among perioperative patients, as is recommended by the CDC for antimicrobial stewardship programs, researchers reported.

BOSTON — There are a handful of “novel and important” treatments that primary care providers should be aware of this year, according to a speaker.

HOUSTON — Antibiotic use in urology outpatient settings may be “substantially underestimated” if only prescriptions made during in-person encounters are considered, researchers found.

ATLANTA — A remote, team-based approach with immediate initiation of necessary medications improved guideline-directed medical therapy use at 6 months for patients with diabetes at high CV or renal risk, researchers reported.